Paul advises on mergers and acquisitions, joint ventures, strategic alliances and general corporate matters, and represents clients before the SEC, NYSE and Nasdaq.
Allen & Overy LLP
1221 Avenue of the Americas
J.D., Yale Law School, 1995
B.A., Princeton University, magna cum laude, 1991
Apax Partners and its portfolio company Neuraxpharm Group, a leading European specialty pharmaceutical company focused on the central nervous system, on the acquisition of the assets and rights related to prescription brand Buccolam® from Takeda Pharmaceutical Company
GSK, the multinational pharmaceutical company, on three separate divestures from their Consumer Healthcare business as part of a GBP1bn divestiture program.
IHS Towers, one of the largest independent owners, operators and developers of shared telecommunications infrastructure in the world by tower count, on its agreement to purchase Brazilian-headquartered infrastructure solutions provider Cell Site Solutions from affiliates of Goldman Sachs and Centaurus Capital LP.
EQT in its acquisition of Igenomix, a global leader in women’s health and reproductive genetic services for IVF (In Vitro Fertilization) clinics, with 15 laboratories across 13 countries.